АЛЕФ-2

ALEPH-2 is a rare psychedelic of the substituted amphetamine and phenethylamine classes, belonging to both the Aleph series and DOx family. First described by Alexander Shulgin in 1978 and later documented in his 1991 book PiHKAL, it functions as the DOx analogue of 2C-T-2. It is reported to be potent and to produce long-lasting, highly visual experiences. Very little human use data is available.

Also known as: Dot-2, 4-ethylthio-2,5-dimethoxyamphetamine

Classification

Chemical: Amphetamine
Chemical: Phenethylamine
Psychoactive: Psychedelic
Psychoactive: Stimulant
Tag: Hallucinogen
Tag: Research-Chemical
Tag: Tentative

Effects

Pupil Dilation
Temperature Regulation Suppression
Stimulation
Muscle Tension
Muscle Tremors
Bruxism
Derealization
Euphoria
Empathy Enhancement
Introspection
Confusion
Amnesia
Appetite Suppression
Auditory Enhancement
Tactile Enhancement
Drifting
Color Enhancement
External Hallucination

Routes of Administration

Oral

Dosage

Heavy: 8 mg+
Light: 3 – 5 mg
Common: 5 – 7 mg
Strong: 7 – 8 mg
Threshold: ~1 mg

Duration

Onset: 0.67-2 h
After Effects: 12-24 h
Peak: 3-6 h
Offset: 6-14 h
Total Duration: 8-16 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu